How has Nurix Therapeutics, Inc.'s interest income and other, net changed year-over-year?

Nurix Therapeutics, Inc.'s interest income and other, net decreased by 18.3% year-over-year, from $6.51M to $5.32M.

What is the long-term trend for Nurix Therapeutics, Inc.'s interest income and other, net?

Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s interest income and other, net has grown at a 127.3% compound annual growth rate (CAGR), from $823K to $21.97M.

Nurix Therapeutics, Inc. NRIX Interest income and other, net

Interest income and other, net at other companies

Celldex TherapeuticsCLDX

——

MBX Biosciences, Inc.MBX

——

BioCryst PharmaceuticalsBCRX

——

Other financials

Income statement

See full

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

See full

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

See full

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

See full

Market cap$1.95B+40.1%

Enterprise value$1.94B+45.1%

P/S27.2×+2.5×

Profitability

See full

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

See full

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s interest income and other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s interest income and other, net?: Nurix Therapeutics, Inc. (NRIX) reported interest income and other, net of $5.32M in Q4 2025.
How has Nurix Therapeutics, Inc.'s interest income and other, net changed year-over-year?: Nurix Therapeutics, Inc.'s interest income and other, net decreased by 18.3% year-over-year, from $6.51M to $5.32M.
What is the long-term trend for Nurix Therapeutics, Inc.'s interest income and other, net?: Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s interest income and other, net has grown at a 127.3% compound annual growth rate (CAGR), from $823K to $21.97M.